These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9648455)

  • 21. [Apoptosis--basic regulatory mechanism of bone remodeling].
    Rusu T
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):674-9. PubMed ID: 14974209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is BMU-coupling a strain-regulated phenomenon? A finite element analysis.
    Smit TH; Burger EH
    J Bone Miner Res; 2000 Feb; 15(2):301-7. PubMed ID: 10703932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.
    Vaes G
    Clin Orthop Relat Res; 1988 Jun; (231):239-71. PubMed ID: 3286076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The physiopathology of osteoporosis: the role of local factors].
    Girasole G; Giuliani N
    Ann Ital Med Int; 1995 Oct; 10 Suppl():9S-17S. PubMed ID: 8562275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone cell interactions and regulation by inflammatory mediators.
    Oates TW; Cochran DL
    Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of the basic multicellular unit and the pathophysiology of osteoporosis.
    Jilka RL
    Med Pediatr Oncol; 2003 Sep; 41(3):182-5. PubMed ID: 12868116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecules which are involved in osteoclastic bone resorption: from the aspect of targets of treatment for osteoporosis].
    Take I; Takahash N; Kurihara S
    Clin Calcium; 2005 May; 15(5):741-6. PubMed ID: 15876734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of transforming growth factor-beta in bone remodeling.
    Bonewald LF; Mundy GR
    Clin Orthop Relat Res; 1990 Jan; (250):261-76. PubMed ID: 2403492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen effects on osteoblasts and osteoclasts.
    Oursler MJ; Landers JP; Riggs BL; Spelsberg TC
    Ann Med; 1993 Aug; 25(4):361-71. PubMed ID: 8217102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of bone quality. Bone remodeling and bone quality].
    Sano G; Matsuo K
    Clin Calcium; 2008 Mar; 18(3):315-20. PubMed ID: 18310818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How the osteoclast degrades bone.
    Blair HC
    Bioessays; 1998 Oct; 20(10):837-46. PubMed ID: 9819571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of bone homeostasis by bone cells].
    Nakashima T
    Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trabecular architecture can remain intact for both disuse and overload enhanced resorption characteristics.
    Tanck E; Ruimerman R; Huiskes R
    J Biomech; 2006; 39(14):2631-7. PubMed ID: 16214155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptides and growth regulatory factors in bone.
    Mundy GR
    Rheum Dis Clin North Am; 1994 Aug; 20(3):577-88. PubMed ID: 7984779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone remodeling and the osteoclast.
    Teitelbaum SL
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S523-5. PubMed ID: 8122522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Local factors in bone repair].
    Bergmann P
    Rev Med Brux; 1989 Dec; 10(10):419-23. PubMed ID: 2690263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytokines and osteoclastic action].
    Chenu C
    Pathol Biol (Paris); 1989 Jun; 37(6):768-75. PubMed ID: 2674878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.